Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.260
+0.010 (0.80%)
At close: Oct 9, 2026, 4:00 PM EDT
1.230
-0.030 (-2.39%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Cellectis Employees
As of December 31, 2025, Cellectis had 229 total employees, including 224 full-time and 5 part-time employees. The number of employees increased by 7 or 3.15% compared to the previous year.
Employees
229
Change (1Y)
7
Growth (1Y)
3.15%
Revenue / Employee
$278,703
Profits / Employee
-$285,214
Market Cap
91.82M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 229 | 7 | 3.15% | 224 | 5 |
| Dec 31, 2024 | 222 | 1 | 0.45% | 216 | 6 |
| Dec 31, 2023 | 221 | -16 | -6.75% | 216 | 5 |
| Dec 31, 2022 | 237 | -63 | -21.00% | 231 | 6 |
| Dec 31, 2021 | 300 | 19 | 6.76% | 294 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PolyPid | 75 |
| ImmuCell | 73 |
| Neumora Therapeutics | 63 |
| OnKure Therapeutics | 45 |
| Biomea Fusion | 37 |
| Equillium | 15 |
| Cognition Therapeutics | 14 |
| Atara Biotherapeutics | 10 |
CLLS News
- 1 day ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS - PRNewsWire
- 3 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS - GlobeNewsWire
- 3 days ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 8 days ago - Cellectis Unveils In Vivo Gene-Editing Plans for Severe Lipid Disorders - MarketBeat
- 9 days ago - Cellectis Transcript: Stifel 2026 Virtual Cardiometabolic Forum - Transcripts
- 10 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS - GlobeNewsWire
- 20 days ago - CLLS Investors Have Opportunity to Join Cellectis S.A. Fraud Investigation with SBS Law - Business Wire
- 22 days ago - CLLS INVESTOR ALERT: Investigation of Cellectis S.A. Announced by Holzer & Holzer, LLC - GlobeNewsWire